RadNet Income After Taxes 2010-2024 | RDNT

RadNet income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
RadNet Annual Income After Taxes
(Millions of US $)
2024 $39
2023 $30
2022 $34
2021 $44
2020 $-2
2019 $23
2018 $38
2017 $2
2016 $8
2015 $9
2014 $2
2013 $2
2012 $60
2011 $7
2010 $-18
2009 $-7
RadNet Quarterly Income After Taxes
(Millions of US $)
2024-12-31 $14
2024-09-30 $12
2024-06-30 $7
2024-03-31 $5
2023-12-31 $6
2023-09-30 $24
2023-06-30 $15
2023-03-31 $-14
2022-12-31 $5
2022-09-30 $6
2022-06-30 $14
2022-03-31 $8
2021-12-31 $1
2021-09-30 $21
2021-06-30 $8
2021-03-31 $14
2020-12-31 $11
2020-09-30 $10
2020-06-30 $-9
2020-03-31 $-14
2019-12-31 $13
2019-09-30 $5
2019-06-30 $8
2019-03-31 $-2
2018-12-31 $31
2018-09-30 $6
2018-06-30 $6
2018-03-31 $-5
2017-12-31 $-7
2017-09-30 $4
2017-06-30 $6
2017-03-31 $-1
2016-12-31 $4
2016-09-30 $2
2016-06-30 $3
2016-03-31 $-1
2015-12-31 $1
2015-09-30 $8
2015-06-30 $4
2015-03-31 $-4
2014-12-31 $4
2014-09-30 $5
2014-06-30 $5
2014-03-31 $-12
2013-12-31 $1
2013-09-30 $0
2013-06-30 $3
2013-03-31 $-1
2012-12-31 $53
2012-09-30 $5
2012-06-30 $3
2012-03-31 $-1
2011-12-31 $8
2011-09-30 $-1
2011-06-30 $2
2011-03-31 $-2
2010-12-31 $5
2010-09-30 $-3
2010-06-30 $-14
2010-03-31 $-6
2009-12-31 $2
2009-09-30 $-3
2009-06-30 $-3
2009-03-31 $-3
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.587B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
Encompass Health (EHC) United States $12.183B 25.83
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.25
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00